Codex
Why It Trades Here
Religare trades at a premium to its realized returns because the market is paying for post-cleanup optionality while current consolidated earnings remain volatile and thin. The single metric most likely to rerate or derate the stock is sustainable group ROE: if it moves into low-double digits with cleaner profit mix, valuation can hold; if it stays around mid-single digits, multiple compression risk is high.
Current Price (₹)
Market Cap (₹ Cr)
P/E (x)
P/B (x)
ROE
ROCE
TTM EPS (₹)
The valuation moved from single-digit implied P/E on FY2023 one-off earnings to ~72x on TTM EPS, which explains why earnings quality matters more than revenue growth right now.
Revenue and Earnings Power
FY2023 earnings were driven by non-core gains, while FY2024-FY2025 reverted to low core profitability. That is the main reason reported P/E screens expensive even after deleveraging.
Cash Generation and Per-Share Economics
No buyback support appears in the local dataset, payout ratio is zero across annual periods, and dilution has carried a meaningful part of capital history.
Balance Sheet Stress vs Flexibility
Peer Gap Snapshot
The numbers confirm a real deleveraging and liquidity rebuild. They contradict a fully earned premium-multiple story because recurring earnings and ROE are still weak versus valuation. Next quarter, watch consolidated ROE and core operating profitability in the insurance-led earnings mix; those are the variables most likely to move the multiple.